News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

10/20/2020 | Atriva Therapeutics GmbH

Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19 Atriva’s ATR-002 molecule is the only host-cell targeting antiviral therapeutic specifically developed to treat severe respiratory inf...
10/07/2020 | The Royal Swedish Academy of Sciences

The Nobel Prize in Chemistry 2020 - Genetic scissors: a tool for rewriting the code of life

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin, Germany and Jennifer A. Doudna, University of California, Berkeley, USA, “for the development of a method for genome editing”. Emmanuelle Charpentier and Jenn...
10/05/2020 | The Nobel Assembly at Karolinska Institutet

The Nobel Prize in Physiology or Medicine 2020 - Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

The Nobel Assembly at Karolinska Institutet has today decided to award the 2020 Nobel Prize in Physiology or Medicine jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus.
10/01/2020 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

Bacteria fed on a customized diet produce biodegradable polymers for alternative packaging in the cosmetics industry

Germany generates around 38 kilograms of plastic waste per capita each year. In a joint project with the University of Stuttgart and LCS Life Cycle Simulation, researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and the Fraunhofer Institute for Process Engineering and Packaging IVV are now working to establis...
10/01/2020 | CeGaT GmbH

CeGaT Tests for Active Corona Infections

Since October 1, anyone who would like to (or has to) be tested for active corona infections can come to CeGaT’s premises without prior appointment. The result is available within 24 hours and can be downloaded via a secure system. For companies and larger groups, CeGaT offers a mobile service for taking nasopharyngeal swabs.
09/30/2020 | Insilico Biotechnology AG

Insilico announces the release of the “Insilico designer” for digital-twin-based design of experiments optimized for machine learning applications

(Stuttgart) - Insilico Biotechnology AG has announced the release of a new product, the Insilico Designer for Digital-Twin-based Design of Experiments (DoE). The Insilico Designer is used to develop an experimental design for bioreactor runs that reduces the experimental burden while resulting in information-rich data that is optimized for machine ...
09/30/2020 | Universitätsklinikum Tübingen

The role of T-cells in SARS-CoV-2 virus defense

Current work published in Nature Immunology Our immune system can efficiently fend off viral diseases. Two types of immune cells play an important role in this process: The T-cells, which firstly can directly destroy virus-infected cells and secondly enable the formation of efficient, virusneutralizing antibodies by B-cells. These two cell types...
09/29/2020 | CureVac AG

CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate

Study conducted in Peru and Panama Trial involves 690 participants, including older adults Evaluation of safety, reactogenicity and immunogenicity
09/29/2020 | CeGaT GmbH

Update and Extension of the Panel for Genetic Eye Diseases

CeGaT has updated and expanded the Diagnostic Panel for Genetic Eye Diseases. As part of the regular updates, the panel was revised according to the current scientific knowledge, thereby increasing its diagnostic sensitivity.
09/29/2020 | immatics biotechnologies GmbH

Immatics Appoints Arnd Christ as Chief Financial Officer

Tuebingen, Germany and Houston, Texas, September 29, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, announced today that Arnd Christ will join its leadership team as Chief Financial Officer (CFO) as of October...
09/25/2020 | Bosch Healthcare Solutions GmbH

Bosch’s new rapid coronavirus test delivers reliable results in 39 minutes

The world’s fastest PCR test for SARS-CoV-2 Rapid test is particularly suited to decentralized use in mobile test centers. Bosch CEO Dr. Volkmar Denner: “We can put people’s minds at ease even more quickly.” Bosch test has a sensitivity of 98 percent and a specificity of 100 percent. Simultaneous testing of five people with one test car...
09/24/2020 | Max-Planck-Institut für Intelligente Systeme

Solar-battery effect enables a new light-driven organic microswimmer to operate in the dark

An interdisciplinary team of scientists at the Max Planck Institutes for Intelligent Systems and Solid State Research has developed a biocompatible microswimmer made of carbon nitride, which they can propel forward through light. The particle can also store solar energy similar to miniature solar cells equipped with batteries, and can thus also swi...
09/18/2020 | Ovesco Endoscopy AG

EFTR with the FTRD® should be considered as an alternative to surgery in gastrointestinal lesions that are not amenable to conventional endoscopic resection

A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal lesions showed a R0 resection rate of 82 %, a full-thickness resection rate of 83 %, and an enbloc resection rate of 95 %. The pooled estimate for perfora...
09/16/2020 | Universität Stuttgart

Building materials like insect exoskeletons

The Carl Zeiss Foundation supports a project to research chitin as a basis for smart materials Chitin is the main component of the exoskeletons of insects, spiders, and crustaceans and ensures, for example, that an insect exoskeleton is both robust and flexible. A research group led by Prof. Sabine Laschat at the University of Stuttgart wants to...
09/15/2020 | immatics biotechnologies GmbH

Immatics Appoints Biotech Executive Eliot Forster to Board of Directors

Tuebingen, Germany and Houston, Texas, September 15, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, announced today the appointment of Eliot Forster, PhD, to its Board of Directors. Forster currently serves as Chief Exe...
09/14/2020 | Universität Stuttgart

CMOS chip projects ultrasound movies

Scientists of the Micro, Nano and Molecular Systems Lab at the Max Planck Institute for Intelligent Systems and the Institute of Physical Chemistry at the University of Stuttgart have developed a digital chip that can be used to project movies with ultrasound. The researchers report on this in an article in the magazine "Nature Communications". The...
09/10/2020 | CeGaT GmbH

Update and Extension of Tumor Diagnostics (TUM)

Diagnostics based on the analysis of tumor tissue plays an increasingly relevant role in the treatment of patients with tumor diseases. The more comprehensive the diagnostics, the faster the treating physicians receive all the information relevant for therapy decisions. Time is crucial for the patient, and the highest possible quality must be guara...
09/10/2020 | immatics biotechnologies GmbH

Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment

IMA204 ACTengine® cell therapy program directed at novel tumor target COL6A3 exon 6 prevalently expressed at high copy numbers in tumor stroma across many solid cancers Two affinity-enhanced TCR candidates designed using Immatics’ proprietary XCEPTOR™ platform demonstrates high specificity and potency; one of the candidates shows full function...
09/07/2020 | BioLAGO e.V. - das Gesundheitsnetzwerk

Digital ecosystem for customized patient care of the future

In order to guarantee the best possible therapy for patients, medical products must be constantly improved. Therefore, a nationwide project was launched in 2020. The project KIKS aims to develop a digital ecosystem for medical data - AIQNET.
09/04/2020 | Ovesco Endoscopy AG

OTSC® clipping for recurrent peptic ulcer bleeding is cost-effective as compared to a repeat of standard treatment

A cost analysis based on mathematic modelling determined the average cost of repeating standard treatment in patients with persistent/recurrent peptic ulcer bleeding ($ 6,578) and the average cost of second-line OTSC treatment after failed standard therapy, which was lower (at average $ 6,298). The average cost of standard treatment was based on th...